| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.009 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |